Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-emptive Diclectin for Severe Nausea and Vomiting of Pregnancy
NCT00293644Phase 3Completed
- Sponsor
- SickKids
- Start
- Feb 2006
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of doxylamine succinate + pyridoxine in nausea and vomiting of pregnancy (NVP) and hyperemesis gravidarum (HG) (3 arms), sponsored by SickKids. Primary endpoint: Rate of severe Nausea and Vomiting of Pregnancy or Hyperemesis Gravidarum. Started Feb 2006; status: completed.
02
Drugs
doxylamine succinate + pyridoxine
03
Conditions
nausea and vomiting of pregnancy (NVP)hyperemesis gravidarum (HG)
Beyond the preview
Go deeper on NCT00293644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00293644.